A new study suggests that forcing treatment-resistant breast cancer cells to die through a process called necroptosis could do more than eliminate tumor cells – it may also boost the body’s immune response. Using patient-derived 3D mini-tumors (organoids), researchers found that necroptosis caused cancer cells to release danger signals that activated immune pathways, including those involving natural killer (NK) cells, which help destroy tumors. Unlike apoptosis, a “silent” form of cell death, necroptosis alerts the immune system, potentially strengthening anti-cancer defenses. These findings highlight a promising strategy for future cancer therapies while showcasing organoids as powerful models for studying disease and testing new treatments.
Read more at MedicalXpress